MedPath

CHRISTOPHER BELL

🇳🇿New Zealand
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:0
Completed:7

Trial Phases

4 Phases

Early Phase 1:3
Phase 1:1
Phase 2:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Early Phase 1
3 (33.3%)
Phase 2
3 (33.3%)
Not Applicable
2 (22.2%)
Phase 1
1 (11.1%)

Ergogenic Effects of Sportlegs

Phase 1
Completed
Conditions
Performance Enhancing Product Use
First Posted Date
2024-04-17
Last Posted Date
2024-07-12
Lead Sponsor
Christopher Bell
Target Recruit Count
19
Registration Number
NCT06371521
Locations
🇺🇸

Colorado State University, Fort Collins, Colorado, United States

Does Mirabegron Increase the Body Heat Generated by the Nervous System

Early Phase 1
Completed
Conditions
Thermoregulation
Interventions
First Posted Date
2023-08-25
Last Posted Date
2024-06-06
Lead Sponsor
Christopher Bell
Target Recruit Count
19
Registration Number
NCT06011265
Locations
🇺🇸

Colorado State University, Fort Collins, Colorado, United States

Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota

Not Applicable
Completed
Conditions
Diabetes
First Posted Date
2022-03-17
Last Posted Date
2024-07-03
Lead Sponsor
Christopher Bell
Target Recruit Count
30
Registration Number
NCT05285449
Locations
🇺🇸

Colorado State University, Dept. of Health and Exercise Science, Fort Collins, Colorado, United States

Ergogenic Properties of Magnesium Supplementation

Not Applicable
Completed
Conditions
Exercise Performance
Gut -Microbiota
Mitochondrial Function
First Posted Date
2022-03-16
Last Posted Date
2024-05-16
Lead Sponsor
Christopher Bell
Target Recruit Count
41
Registration Number
NCT05282693
Locations
🇺🇸

Colorado State University, Dept. of Health and Exercise Science, Fort Collins, Colorado, United States

Influence of Edible Marijuana on Endurance Exercise Performance

Early Phase 1
Completed
Conditions
Endurance Exercise
Interventions
Drug: Placebo
First Posted Date
2022-01-14
Last Posted Date
2024-04-22
Lead Sponsor
Christopher Bell
Target Recruit Count
17
Registration Number
NCT05192239
Locations
🇺🇸

Colorado State University, Dept. of Health and Exercise Science, Fort Collins, Colorado, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath